Ambulatory surgery webinar on malignant hyperthermia

March 15, 2012 - PRLog -- Moving patients suspected to have malignant hyperthermia to a hospital is just one of the topics discussed at the March 26 online live presentation for ambulatory surgical center healthcare professionals and administrative staff hosted by MHAUS and presented by Ronald S. Litman, MD of the Children’s Hospital of Philadelphia and MH Hotline Consultant.

Post your pre-event questions
Click this link to post pre-event questions and to register for the event: http://www.mhaus.org/2374/mhaus-news/ambulatory-webinar-march-26-2012/

What is Malignant Hyperthermia
Malignant Hyperthermia (MH) is an inherited muscle disorder triggered by certain types of anesthesia that may cause a fast-acting life-threatening crisis. The incidence of MH is low, but, if untreated, the mortality rate is high. Great advances in the understanding of MH have been made since it was first recognized in the early 1960s, but the nature of the fundamental defect(s) is still unknown. More information at: http://www.mhaus.org

About MHAUS
Founding in 1981 MHAUS promotes optimum care and scientific understanding of MH and related disorders by encouraging medical professionals and patients and families to prepare for MH through education and testing, and providing life-saving services such as the MH 24-hour Hotline.

Contact
Michael Wesolowski
607-674-7901

# # #

Malignant Hyperthermia (MH) is an inherited muscle disorder triggered by certain types of anesthesia that may cause a fast-acting life-threatening crisis. The incidence of MH is low, but, if untreated, the mortality rate is high.